Yunlong Jia
Overview
Explore the profile of Yunlong Jia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
375
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Han T, Wang Y, Ma S, Li M, Zhu N, Tao S, et al.
Adv Sci (Weinh)
. 2022 Sep;
9(30):e2203474.
PMID: 36047633
Carbon dots (CDs) or carbonized polymer dots (CPDs) are an emerging class of optical materials that have exceptional applications in optoelectronic devices, catalysis, detection, and bioimaging. Although cell studies of...
12.
Zhao Y, Liu Y, Jia Y, Wang X, He J, Zhen S, et al.
J Cancer Res Clin Oncol
. 2022 Aug;
149(7):3469-3483.
PMID: 35951090
Purpose: The identification of robust predictive biomarkers of the response to programmed cell death-1 (PD-1) blockade remains a critical concern. Here, we investigated on fibroblast activation protein (FAP) as a...
13.
Lv W, Jia Y, Wang J, Duan Y, Wang X, Liu T, et al.
Cell Death Discov
. 2022 Feb;
8(1):60.
PMID: 35149697
Epithelial ovarian cancer (EOC) is one of the most frequent and fatal gynecologic malignant tumors resulting in an unsatisfying prognosis. Long non-coding RNAs (lncRNAs) play pivotal roles in the tumorigenesis...
14.
Jia Y, Tian C, Wang H, Yu F, Lv W, Duan Y, et al.
Mol Cancer
. 2021 Dec;
20(1):162.
PMID: 34893064
Background: Cis-diamminedichloro-platinum (CDDP)-based chemotherapy regimens are the most predominant treatment strategies for patients with esophageal squamous cell carcinoma (ESCC). Dysregulated long non-coding RNAs (lncRNAs) contribute to CDDP resistance, which results...
15.
Jia Y, Bleicher F, Reboulet J, Merabet S
Methods Mol Biol
. 2021 Jul;
2350:173-190.
PMID: 34331286
Deciphering protein-protein interactions (PPIs) in vivo is crucial to understand protein function. Bimolecular fluorescence complementation (BiFC) makes applicable the analysis of PPIs in many different native contexts, including human live...
16.
Duan Y, Jia Y, Wang J, Liu T, Cheng Z, Sang M, et al.
Cell Death Dis
. 2021 Jun;
12(6):587.
PMID: 34099633
Long noncoding RNAs (lncRNAs) emerge as essential roles in the regulation of alternative splicing (AS) in various malignancies. Serine- and arginine-rich splicing factor 1 (SRSF1)-mediated AS events are the most...
17.
Jia Y, Liu L, Shan B
Ann Transl Med
. 2020 Nov;
8(17):1095.
PMID: 33145314
Immunotherapy has become a powerful clinical strategy in cancer treatment. Immune checkpoint inhibitors (ICIs) have opened a new era for cancer immunotherapy. Nowadays, the number of immunotherapy drug approvals has...
18.
Zhang X, Wang J, Jia Y, Liu T, Wang M, Lv W, et al.
Cancer Cell Int
. 2019 Sep;
19:226.
PMID: 31496920
Background: Bridging integrator 1 (BIN1) has showed outstanding tumor-suppressive potential via inhibiting c-MYC-mediated tumorigenesis. However, a frequent phosphorylation of c-MYC at Ser-62 site could block the BIN1/c-MYC interaction and limits...
19.
Wang J, Liu T, Wang M, Lv W, Wang Y, Jia Y, et al.
J Cell Biochem
. 2019 Sep;
121(2):946-953.
PMID: 31478261
Decreased bridging integrator 1 (BIN1) expression has great significance in promoting the progression of malignant tumors. Reduced messenger RNA expression is partly due to aberrant alternative splicing (AS). However, the...
20.
Jia Y, Duan Y, Liu T, Wang X, Lv W, Wang M, et al.
Cell Death Dis
. 2019 Aug;
10(8):573.
PMID: 31363080
Emerging evidence suggests that long noncoding RNA (lncRNA) plays pivotal roles in regulating various biological process in human cancers. Titin-antisense RNA1 (TTN-AS1) has been regarded as a tumor promoting lncRNA...